Jonathan P. Foster insider trades

Open-market stock purchases and sales by Jonathan P. Foster, Chief Financial Officer at Moleculin Biotech, Inc, from SEC Form 4 filings since Mar 13, 2014.

Track record: 100% of 4 scored buys are up 5% or more since purchase, averaging +211%.

Recent trades

DateStockTradeValue
Jun 22, 2026MBRX Moleculin Biotech, IncSold (not open market)$128
Jun 22, 2026MBRX Moleculin Biotech, IncBought (not open market)—
Jun 20, 2026MBRX Moleculin Biotech, IncBought (not open market)—
Jun 20, 2026MBRX Moleculin Biotech, IncSold (not open market)$89
Feb 18, 2026EMPD Empery Digital IncSold (not open market)—
Feb 18, 2026EMPD Empery Digital IncSold (not open market)—
Nov 12, 2025MBRX Moleculin Biotech, IncBought (not open market)$294K
Nov 12, 2025MBRX Moleculin Biotech, IncBought (not open market)—
Nov 4, 2025MBRX Moleculin Biotech, IncSold (not open market)$2.5K
Nov 4, 2025MBRX Moleculin Biotech, IncBought (not open market)—

Companies traded

  • MBRX Moleculin Biotech, Inc: 4 buys, last Jun 22, 2026
  • EMPD Empery Digital Inc: other filings, last Feb 18, 2026
  • VLCN Volcon, Inc: other filings, last Jul 21, 2025
  • SOLY Soliton, Inc: other filings, last Dec 16, 2021
  • INFU InfuSystem Holdings, Inc: 4 buys, last Aug 18, 2015

Get free alerts when Jonathan P. Foster files a new trade →